PAOLA-1 STUDY Platine, Avastin and OLAparib in 1 st line of advanced high grade epithelial ovarian, fallopian tube, or primary peritoneal cancer. Randomized, Double-Blind, Phase III Trial of Olaparib vs. Placebo in Patients with Advanced FIGO Stage IIIB – IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer treated with standard First-Line Treatment, Combining Platinum-Taxane Chemotherapy and Bevacizumab Concurrent with Chemotherapy and in Maintenance . Principal Investigator : Pr Isabelle Ray-Coquard, MD Centre Léon BERARD, Lyon, France
PAOLA -1 Study design
Recruitment status_13/05/2016 454 registered patients including : - 166 randomized patients - 103 screened failure
Recommend
More recommend